Evaluation of adrenergic, cholinergic and dopaminergic involvement in the inhibition of hyperreactivity and interanimal aggression by the medial hypothalamus in the rat.
D000374:Aggression / Q000502:physiology*; D000818:Animals; D004298:Dopamine / Q000502:physiology*; D004347:Drug Interactions; D006801:Humans; D007031:Hypothalamus / Q000502:physiology*; D007033:Hypothalamus, Middle / Q000502:physiology*; D008012:Lidocaine / Q000494:pharmacology; D008297:Male; D009043:Motor Activity / Q000502:physiology*; D010275:Parasympathetic Nervous System / Q000502:physiology*; D010276:Parasympatholytics / Q000494:pharmacology; D051381:Rats; D013564:Sympathetic Nervous System / Q000502:physiology*; D013565:Sympatholytics / Q000494:pharmacology; D014043:Tolazoline / Q000494:pharmacology
D010276:Parasympatholytics; D013565:Sympatholytics; D008012:Lidocaine; D014043:Tolazoline; D004298:Dopamine